Peter Bains
Chief Executive Officer at BIOCON LIMITED
Net worth: 231 114 $ as of 2024-03-30
Network origin in Peter Bains first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
The University of Sheffield
43
| College/University | Other Consumer Services | 43 |
32
| Public Company | Pharmaceuticals: Major | 32 |
| Public Company | Biotechnology | 24 | |
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Miscellaneous Commercial Services | 14 | |
| Public Company | Pharmaceuticals: Major | 12 | |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.
8
| Holding Company | Biotechnology | 8 |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments.
5
| Private Company | Financial Conglomerates | 5 |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Fermenta Biotech Ltd. /Old/
 Fermenta Biotech Ltd. /Old/ BiotechnologyHealth Technology Fermenta Biotech Ltd. manufactures biological products. It supplies Vitamin D3, cholecalciferol also know as Vitamin D3 for further applications in global pharmaceutical, food, veterinary and feed industries (premix), cholecalciferol solutions for use in human food supplements, Vitamin D3 resin in oil and Vitamin D3 500 feed grade for use in animal feed supplements and activated dimethicone powder (Silicon Powder) for antiflatulent use. The company was founded in 1986 and is headquartered in Thane, India.
3
| Extinct | Biotechnology | 3 |
Apterna Ltd.
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter Bains via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
| INFOSYS LIMITED | Information Technology Services | Director/Board Member Director/Board Member | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member President | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| GSK PLC | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin | |
| University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| Government of India | Sovereign | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| LARSEN & TOUBRO LIMITED | Engineering & Construction | Director/Board Member Director/Board Member Director/Board Member | |
| ALLIANCE PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Imperial College London | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Glentec International | Director/Board Member Director/Board Member | ||
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Director/Board Member Undergraduate Degree Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Purdue University | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Madras | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Mumbai | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Durham | College/University | Masters Business Admin Graduate Degree | |
| Keck Graduate Institute of Applied Life Sciences | College/University | Director/Board Member Director/Board Member | |
| The University of Nottingham | College/University | Undergraduate Degree Undergraduate Degree | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Delhi | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| University of Pune | College/University | Graduate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
U.S.-India Business Council
 U.S.-India Business Council Miscellaneous Commercial ServicesCommercial Services The U.S.-India Business Council operates as a business advocacy organization. The private company is based in Washington. The CEO of the American company is Joseph Gilmour. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Institute of Company Secretaries of India
 Institute of Company Secretaries of India Other Consumer ServicesConsumer Services Institute of Company Secretaries of India operates as a recognized professional body in India to develop and regulate the profession of Company Secretaries in India. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal | |
Confederation of Indian Industry
 Confederation of Indian Industry Miscellaneous Commercial ServicesCommercial Services The Confederation of Indian Industry operates as a business association. The non-profit company is based in India and has subsidiaries in Singapore and India. The Indian company was founded by Ashok Khanna. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal President Director/Board Member Human Resources Officer | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Indian Institute of Technology Bombay | College/University | Corporate Officer/Principal Undergraduate Degree | |
Biocon Research Ltd.
 Biocon Research Ltd. Pharmaceuticals: MajorHealth Technology Part of Biocon Ltd., Biocon Research Ltd. is an Indian company that develops and sells biotechnology products. The private company is based in Bangalore, India. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Biocon Biologics Ltd. (India)
 Biocon Biologics Ltd. (India) Pharmaceuticals: MajorHealth Technology Biocon Biologics India Ltd. operates as a biotech company. It develops treatments for chronicle diseases. The company is headquartered in Bengaluru, India. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Public Communications Contact Compliance Officer Corporate Officer/Principal Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Founder Chief Operating Officer | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Founder | |
Alliance Pharmaceuticals Ltd. (United Kingdom)
 Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The private company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Mazumdar Shaw Medical Foundation | Director/Board Member Director/Board Member | ||
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Founder | |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bicara Therapeutics, Inc. is a company that develops first-in-class bifunctional antibodies for the treatment of solid tumors. The company is based in Cambridge, MA. The company's lead product candidate, bca101, is a first-in-class egfr/tgf-?-trap bifunctional antibody in clinical development for multiple tumor types. The company's bifunctional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Bicara has a deep pipeline of promising bifunctional antibodies and other biologics for treating solid tumors. The CEO of the company is Claire Mazumdar. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 19 |
| India | 16 |
| United Kingdom | 12 |
| Ireland | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 20 |
| Consumer Services | 19 |
| Finance | 4 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 686 |
| Corporate Officer/Principal | 220 |
| Independent Dir/Board Member | 198 |
| Chairman | 117 |
| Founder | 61 |
Most connected contacts
| Insiders | |
|---|---|
| Suresh Narasappa Talwar | 73 |
| Kiran Mazumdar-Shaw | 66 |
| Naina Lal Kidwai | 47 |
| Paul Blackburn | 46 |
| Daniel Bradbury | 45 |
| Damodaran Meleveetil | 44 |
| Charles Cooney | 37 |
| John Russell Fotheringham Walls | 34 |
| Deepa Pakianathan | 32 |
| Michael Wyzga | 31 |
| Declan Doogan | 28 |
| Anders Olof Adolf Ekblom | 27 |
| Bobby Kanubhai Parikh | 26 |
| Lizabeth Zlatkus | 23 |
| Julia Gregory | 22 |
- Stock Market
- Insiders
- Peter Bains
- Company connections
